An owner who works as the pharmacist in a busy Canadian independent pharmacy usually takes home far more than a staff pharmacist, because they collect two things: the pharmacist’s wage and the profit the business makes. In the deals we see, owners of busy owner-operated stores commonly report about $200,000 to $500,000 a year of total owner benefit (pharmacist pay plus business profit, before personal tax), against a staff pharmacist median of roughly $106,000 to $131,000 depending on the province. Small stores earn less, large stores can earn much more, and a new owner who borrowed to buy the store keeps a lot less for the first several years.
The salary figures you see online, around $105,000 to $117,000 for a “pharmacy owner”, miss most of this. This guide from PharmacyBroker.ca breaks owner income into its three layers, shows the margin data, walks through real anonymised figures from pharmacies we have listed or sold since 2025, and shows what is left after the bank and the tax collector.
Why Glassdoor says pharmacy owners earn about $105,000
Search for pharmacy owner salary in Canada and the first answers come from salary sites. When we checked Glassdoor in October 2026, the Canadian “Pharmacy Owner” figure was $104,607 a year, and the page showed 2 salaries, submitted in June 2020 and March 2022. The “Pharmacist Owner” figure was $116,732 from 5 salaries, and two of those five reported additional pay of $260,000 and $330,000 on top of their base.
Three problems:
The samples are tiny. Two or five self-reported entries, some several years old, are not a picture of anything.
They show salary only. Many owners pay themselves roughly a pharmacist’s wage as salary, then take the rest as dividends, leave it in the company, or move it to a holding company. None of that shows up in a salary survey.
They miss the asset. An owner is also building a business that can be sold. That value does not appear in any annual pay figure.
So the salary number is close to a staff pharmacist’s wage for a simple reason: for many owners, the salary line is a staff pharmacist’s wage. The rest of the income is somewhere else.
The three layers of owner income
The clearest way to think about what a pharmacy owner makes is in three layers.
Layer 1: the pharmacist wage
If you own the store and work the bench as pharmacist-manager, part of what you “make” is a wage you would earn anyway as an employee. That is the baseline every owner should compare against. Job Bank’s median hourly wages for pharmacists (2023 to 2024 data, updated 19 November 2025) give a fair replacement cost. The annual figures are our calculation at 2,080 hours.
| Province | Median hourly wage | About per year |
|---|---|---|
| British Columbia | $52.00 | $108,000 |
| Alberta | $55.00 | $114,000 |
| Saskatchewan | $55.33 | $115,000 |
| Manitoba | $56.00 | $116,000 |
| Ontario | $53.85 | $112,000 |
| Quebec | $63.00 | $131,000 |
| Nova Scotia | $51.00 | $106,000 |
| Canada | $55.49 | $115,000 |
Source: Job Bank, pharmacists (NOC 31120). A pharmacist-manager usually earns above the median. In our EBITDA normalization guide we use a market manager wage of about $115,000 to $125,000, and our valuation calculator uses $125,000 for BC and $130,000 for Alberta.
Layer 2: business profit (normalized EBITDA)
Normalized EBITDA is the profit the store makes after paying a market wage to whoever runs the dispensary, with the owner’s personal expenses, family wages for work not done and one-time costs adjusted out. It is the profit an owner earns as an owner, not as a pharmacist. It is also the number buyers and banks price a pharmacy on.
Seller’s discretionary earnings (SDE) is a simpler idea: normalized EBITDA plus the owner’s own pay. It is the total pool one working owner can take out of the business before debt and tax. If a store has $300,000 of normalized EBITDA after a $120,000 manager wage, its SDE is about $420,000. That is why owner-operators sometimes talk about numbers much larger than any salary survey shows. They are describing SDE, not salary.
Layer 3: what is left after debt and tax
What actually lands in your bank account comes after loan payments and tax. A buyer who borrowed to buy the store hands a large share of layer 2 to the bank for the first 5 to 10 years. Only the interest part of a loan payment is deductible; the principal is paid from profit that has already been taxed. We work through an example below.
How profitable is a Canadian pharmacy? The margin data
There is no public profit survey of Canadian community pharmacies only. The closest hard data is Statistics Canada’s Annual Retail Trade Survey for “health and personal care retailers”. That group includes pharmacies and drugstore chains, but also cosmetics, optical and supplement stores, so treat it as a broad retail category proxy, not a pharmacy benchmark.
| Year | Gross margin | Operating profit margin |
|---|---|---|
| 2022 | 37.6% | 5.9% |
| 2023 | 37.2% | 5.7% |
| 2024 | 36.6% | 5.4% |
Source: Statistics Canada, table 20-10-0083-01. Revenue for the group grew from about $69.1 billion in 2022 to $80.8 billion in 2024, while both margins slipped every year. More sales, slightly thinner margins.
The provincial spread in 2024, same category:
| Province | Gross margin | Operating profit margin |
|---|---|---|
| British Columbia | 39.3% | 5.9% |
| Alberta | 39.8% | 5.5% |
| Saskatchewan | 37.4% | 7.5% |
| Manitoba | 35.6% | 6.0% |
| Ontario | 34.1% | 4.8% |
| Quebec | 38.5% | 5.5% |
Two cautions. First, operating profit in this survey comes after labour costs, so any salary the owner pays themselves is already deducted. It is close to EBITDA, not to owner income. Second, it is an average across a mixed category. On a $3 million store, 5.4 percent is about $162,000, but individual pharmacies land far above and below that, as the examples below show.
For scale, the average Canadian pharmacy outside Quebec filled about 51,875 prescriptions in 2025, roughly 1,000 a week, according to IQVIA data published by the Neighbourhood Pharmacy Association of Canada. Quebec stores averaged 164,325 because of shorter fills and a different model, so counts do not compare across provinces.
Owner income in three examples
The first two examples use real, anonymised figures from pharmacies we have listed in 2025 and 2026. They are seller figures, not audited results, and each is one store, not a survey. The third is an illustration.
A busy owner-operated store: $1.28 million in sales
A clinic-attached store we listed in 2026 had 2025 revenue of about $1.28 million, more than 33,000 prescriptions a year, no debt, and a lease running to 2030. On an owner-operator basis, with the owner working in the dispensary, net profit was about $273,000, or about 21 percent of sales.
That $273,000 is not all “profit” in the layer 2 sense. Part of it is the pharmacist work the owner does. If the owner stepped back, a buyer would set aside a market pharmacist wage before working out normalized EBITDA. But for the owner who works there, it is the pool their pay and their profit both come out of. This store sits in the lower half of the $200,000 to $500,000 range we see for busy owner-operated stores, and it shows how much the clinic relationship, the prescription mix and low overheads can matter on modest revenue.
A large store at the top end: $3.6 million in sales
A clinic-sharing community pharmacy in Alberta, under a national banner, grew revenue from about $3.0 million to $3.6 million over three years. For the year ended March 2026 it reported normalized EBITDA of about $919,000, about 25 percent of sales, and that figure is stated after paying a full replacement pharmacist. It fills about 64,000 prescriptions a year with a prescription margin of about 35 percent.
An owner who worked the bench in that store would also keep the wage the figure already allows for a replacement pharmacist. This is the top of what we see, not a typical store. Larger stores with strong margins can produce normalized EBITDA near or above $900,000, but most stores are nowhere near it.
A buyer’s first five years (illustrative)
This is the example that matters most if you are looking at a pharmacy for sale with a bank loan. It is an illustration using our standard site figures, not a real store.
- Normalized EBITDA: $300,000, after a $120,000 manager wage paid to the owner
- Price: $1,500,000 (5 times EBITDA) plus $250,000 of inventory, so $1,750,000
- Buyer equity: $350,000 (20 percent down)
- Bank loan: $1,400,000 at 5.45 percent (prime of 4.45 percent posted for the week of 7 October 2026, plus 1 percent), 10 year amortization, monthly payments
- Loan payments: about $15,159 a month, or about $181,900 a year
| Year | Interest paid | Principal repaid | Loan balance at year end | EBITDA left after loan payments | Rough corporate tax at 11% | Cash left in the company |
|---|---|---|---|---|---|---|
| 1 | $73,600 | $108,300 | $1,291,700 | $118,100 | $24,900 | $93,200 |
| 3 | $61,200 | $120,700 | $1,056,600 | $118,100 | $26,300 | $91,800 |
| 5 | $47,300 | $134,600 | $794,600 | $118,100 | $27,800 | $90,300 |
The tax column is our rough estimate: 11 percent (the combined BC small business rate) on EBITDA minus interest. It ignores capital cost allowance on equipment and goodwill, which would lower the tax in the early years, and it ignores maintenance spending, which would lower the cash. It is there to show the shape, not to plan your taxes.
What the owner gets in years 1 to 5:
- The $120,000 manager wage, taxed personally like any salary.
- About $90,000 to $93,000 a year of cash left in the company after loan payments and corporate tax, to take as dividends (with personal tax on top) or keep as a cushion.
- About $605,000 of loan principal repaid over five years. That is real wealth, but it is locked in the business until you sell.
So in the first five years, this owner’s total pre-personal-tax income is roughly $210,000 a year, about double a staff pharmacist’s median, while also building equity. After year 10, the loan is gone and the full $300,000 is available on top of the wage.
Two stress tests. At the 6.5 percent rate our financing guide uses as a cautious case, payments rise to about $190,800 a year and the cushion falls to about $109,200 before tax. And any drop in EBITDA comes straight out of that cushion: a $30,000 loss from a fee change or a generic price cut cuts the owner’s surplus by about a quarter, while the loan payment stays exactly the same. This is why lenders test debt coverage and why a vendor take back can make the early years easier.
What moves pharmacy profit
Two stores with the same revenue can earn very different profits. These are the levers we look at first.
Dispensing fees and markups. Public plan fees are low and change slowly, and they differ by province.
| Province | Public plan dispensing fee | Markup or upcharge | How current |
|---|---|---|---|
| British Columbia | PharmaCare pays up to $11 per dispense from 2 January 2026 (was $10); daily dispensing capped at 2 fees per patient per day | Most drugs up to 8% | Fee current (2026); markup from 2021/22 summary |
| Alberta | $12.35 under 84 days supply, $13.50 for 84 days or more, from 1 October 2026 (was $12.15) | 3% plus 7%, second upcharge capped at $100 | Fee current (2026); upcharge from 2021/22 summary |
| Ontario | $8.83 standard ODB fee; rural fees of $9.93, $12.14 or $13.25 | 8.5% under $100 drug cost, stepping down to 5% at $4,000 or more, since 1 April 2024 | Markup current (2026); standard fee from 2021/22 summary |
| Saskatchewan | $11.85 maximum | Tiered by cost | Older figure (March 2021) |
| Manitoba | All-in charge up to $30 per prescription | No separate markup | Older figure |
| Quebec | $10.03 professional fee | No pharmacy markup | Older figure (April 2021) |
| Atlantic provinces | NB up to $11, NS $12.39, PEI $12.36, NL tiered from $11.96 | Varies | Older figures (2021/22) |
Sources: BC PharmaCare newsletter, December 2025; Alberta.ca pharmacy services and fees and Alberta Blue Cross Benefact 1335; Ontario Drug Benefit Formulary, September 2026; older figures from the PMPRB dispensing fee summary and markup summary. Check the older figures with your provincial plan before relying on them. In Alberta, the October 2026 changes also limit daily dispensing and expect longer fills on maintenance drugs, so the fee increase helps some stores and hurts others; our Alberta funding changes article works through the numbers.
Payer mix. Public plans cap what they pay per prescription, while private plans and cash customers pay the store’s usual and customary fee, which can be higher. A store where one public program or one payer is most of the business is more exposed to a single policy change.
Generic pricing. Under the pCPA tiered framework, a generic with three or more competitors is priced at 25 percent of the brand for oral solids, and since April 2018 about 67 common generics have been priced at roughly 10 to 18 percent of brand (PMPRB). Each price cut lowers markup dollars and inventory value, while the fee per prescription stays the same.
Front store. A good front store adds gross margin dollars and foot traffic. A tired one ties up cash in stock that does not move.
Professional services. Assessments, prescribing, minor ailments, vaccines and medication reviews pay fees that do not depend on drug cost. Ontario pays $19 for an in-person minor ailment service, for example. Stores that bill services well have a second income line, though Alberta’s per-pharmacist cap shows these programs can change too.
Rent. Rent is one of the largest fixed costs. A lease at market rent with years left supports profit and value; a big step-up at renewal can erase a year of growth.
Staffing. Labour runs at about 14 percent of revenue in the StatCan category. A store that needs two pharmacists on every shift earns less than one with good technician support and an efficient workflow.
Clinic adjacency. A medical clinic next door can drive prescription volume, as both of our real examples show. It is also a risk if the clinic moves or its doctors retire.
Salary, dividends and the small business deduction
How you take the money out changes how much you keep. A short, factual outline:
- Salary is deductible to the pharmacy corporation, is taxed personally, and creates CPP contributions (5.95 percent each from employee and employer in 2026, up to $4,230.45 each) and RRSP room (18 percent of the previous year’s earned income, up to the annual limit, which was $32,490 for 2025). See CRA CPP rates and CRA RRSP limits.
- The small business deduction gives a Canadian-controlled private corporation a 9 percent federal rate on up to $500,000 of active business income, shared among associated companies. Add the provincial rate: 2 percent in BC (11 percent combined) and 3.2 percent in Ontario (12.2 percent combined), for example. Alberta and Quebec collect their own corporate tax. See CRA corporation tax rates.
- Dividends are paid from profit after corporate tax and taxed personally through the dividend gross-up and tax credit (CRA line 12000).
- Profit left in the company or moved to a holding company is taxed at the low rate for now, which helps repay a loan. But if the group earns more than $50,000 of passive investment income, the $500,000 limit starts to shrink, and it is gone at $150,000 (CRA T4012).
Most owners use a mix. The right split depends on your family, your debt and your plans, so ask your accountant.
Is owning a pharmacy worth it?
For many pharmacists, yes. But it is a trade, not free money.
What the owner gets. Higher income once the store is established: in the deals we see, often two to four times a staff pharmacist’s wage for a busy owner-operated store. Control over how the store runs. And an asset. Most Canadian community pharmacies sell for about 4 to 6 times normalized EBITDA plus inventory at cost, so a store with $300,000 of normalized EBITDA is worth about $1,200,000 to $1,800,000 before inventory. Asking prices we have seen in 2025 and 2026 run from under $500,000 for small or older stores to about $4 million for a high-volume automated store. If the shares qualify, the lifetime capital gains exemption ($1,275,000 per qualifying shareholder in 2026) can shelter much of the gain on a share sale; our retirement guide covers that.
What the owner gives up. Personal guarantees on the bank loan. Longer hours, especially in the first years and whenever a pharmacist quits. Payroll, HR, audits and inventory on top of patient care. Exposure to decisions you do not control: fee changes, generic price cuts, a clinic moving out. And slow starts: a young store we listed, opened in 2022, had reached about 50 prescriptions a day four years later. Building a file takes years, which is why most owners buy an existing store rather than start one.
What the staff pharmacist gets. A steady wage, benefits in many jobs, no debt and the freedom to move. Over a full career, a staff pharmacist who saves well can do fine. The owner’s advantage tends to show up later: after the loan is repaid, and at the sale.
If you are weighing a pharmacy for sale against staying employed, run the numbers both ways over ten years, including the loan, the tax and the likely exit value. Our valuation guide and how much is my pharmacy worth explain how that exit value is set, and who buys pharmacies in Canada explains who will be on the other side when you sell.
Working out your own number
Whether you own a store now or are looking at a pharmacy for sale, the same three steps give you a real answer:
- Separate the layers. Take your total owner pay and profit, set aside a market pharmacist-manager wage for your province, and what is left is your normalized EBITDA. Our EBITDA normalization guide lists what to add back and what not to.
- Subtract the debt. If you are buying, model the loan payments at today’s rate and at a cautious one. The financing guide shows what banks will lend.
- Value the asset. Run the free valuation calculator, which needs no contact details, to see what the business itself is worth.
Owners and buyers ask us these questions every week. If you want a second opinion on a store’s real earnings, or on whether a purchase pencils out after the loan, get in touch. The conversation is confidential, and we are pharmacists who have owned, bought and sold stores ourselves. For tax and legal questions, confirm the details with your accountant and lawyer.